Top

Published in:

Open Access 01-12-2009 | Research

Paracrine sonic hedgehog signalling by prostate cancer cells induces osteoblast differentiation

Authors: Samantha M Zunich, Taneka Douglas, Maria Valdovinos, Tiffany Chang, Wade Bushman, David Walterhouse, Philip Iannaccone, Marilyn LG Lamm

Published in: Molecular Cancer | Issue 1/2009

Abstract

Background

Sonic hedgehog (Shh) and components of its signalling pathway have been identified in human prostate carcinoma and increased levels of their expression appear to correlate with disease progression and metastasis. The mechanism through which Shh signalling could promote metastasis in bone, the most common site for prostate carcinoma metastasis, has not yet been investigated. The present study determined the effect of Shh signalling between prostate cancer cells and pre-osteoblasts on osteoblast differentiation, a requisite process for new bone formation that characterizes prostate carcinoma metastasis.

Results

LNCaP human prostate cancer cells modified to overexpress Shh (designated LNShh cells) and MC3T3 mouse pre-osteoblasts were maintained as mixed populations within the same culture chamber. In this non-conventional mixed culture system, LNShh cells upregulated the expression of Shh target genes Gli1 and Patched 1 (Ptc1) in MC3T3 cells and this was inhibited by cyclopamine, a specific chemical inhibitor of hedgehog signalling. Concomitantly, MC3T3 cells exhibited time-dependent decreased cell proliferation, upregulated alkaline phosphatase Akp2 gene expression, and increased alkaline phosphatase activity indicative of early phase osteoblast differentiation. LNShh cell-induced differentiation was inhibited in MC3T3 cells stably transfected with a dominant negative form of Gli1, a transcription factor that mediates Shh signalling. Interestingly, LNShh cells did not significantly increase the endogenous expression of the osteoblast differentiation transcription factor Runx2 and its target genes osteocalcin and osteopontin. Consistent with these results, exogenous Shh peptide did not upregulate Runx2 expression in MC3T3 cells. However, Runx2 levels were increased in MC3T3 cells by ascorbic acid, a known stimulator of osteoblast differentiation.

Conclusion

Altogether, these data demonstrate that Shh-expressing prostate cancer cells can directly and specifically induce differentiation in pre-osteoblasts via a Gli1-dependent mechanism that does not require transcriptional upregulation of Runx2. Paracrine activation of the Shh pathway in osteoblast progenitors and subsequent induction of osteoblast differentiation could be a mechanism through which high levels of Shh expression in prostate carcinoma contribute to bone metastasis. Targeting of paracrine Shh signalling may provide an effective therapeutic strategy against prostate carcinoma metastasis in bone.

Available only for authorised users

Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ: Metastatic patterns of prostate cancer: an autopsy study of 1, 589 patients. Hum Pathol. 2000, 31: 578-583. 10.1053/hp.2000.6698CrossRefPubMed

Berruti A, Dogliotti L, Bitossi R, Fasolis G, Gorzegno G, Bellina M, Torta M, Porpiglia F, Fontana D, Angeli A: Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. J Urol. 2000, 164: 1248-1253. 10.1016/S0022-5347(05)67149-2CrossRefPubMed

Clark PE, Torti FM: Prostate cancer and bone metastases: medical treatment. Clin Orthop Relat Res. 2003, 415S: S148-S157. 10.1097/01.blo.0000093840.72468.e1.CrossRef

Paget S: The distribution of secondary growths in cancer of the breast. Lancet. 1889, 1: 571-573. 10.1016/S0140-6736(00)49915-0.CrossRef

Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS: Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev. 2001, 20: 333-349. 10.1023/A:1015599831232CrossRefPubMed

Edlund M, Sung S-Y, Chung LWK: Modulation of prostate cancer growth in bone microenvironments. J Cell Biochem. 2004, 91: 686-705. 10.1002/jcb.10702CrossRefPubMed

Cohen MM: The hedgehog signaling network. Am J Med Genet. 2003, 123A: 5-28. 10.1002/ajmg.a.20495.CrossRefPubMed

Iannaccone P, Holmgren R, Lamm MLG, Ahlgren S, Lakiza O, Yoon JW, Walterhouse D: The sonic hedgehog signaling pathway. Inborn Errors of Development. Edited by: Epstein CJ, Erickson RP, Wynshaw-Boris A. 2008, 263-279. Oxford University Press, 2.

Fan L, Pepicelli CV, Dibble CC, Catbagan W, Zarycki JL, Laciak R, Gipp J, Shaw A, Lamm MLG, Munoz A, Lipinski R, Thrasher JB, Bushman W: Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology. 2004, 145: 3961-3970. 10.1210/en.2004-0079CrossRefPubMed

10.

Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Issacs JT, Berman DM, Beachy PA: Hedgehog signaling in prostate regeneration, neoplasia and metastasis. Nature. 2004, 431: 707-712. 10.1038/nature02962CrossRefPubMed

11.

Sanchez P, Hernández AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S, Ruiz i Altaba A: Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA. 2004, 101: 12561-12566. 10.1073/pnas.0404956101PubMedCentralCrossRefPubMed

12.

Sheng T, Li C, Zhang X, Chi S, He N, Chen K, McCormick F, Gatalica Z, Xie J: Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer. 2004, 3: 29-41. 10.1186/1476-4598-3-29PubMedCentralCrossRefPubMed

13.

Walterhouse DO, Lamm MLG, Villavicencio E, Iannaccone PM: Emerging roles for Hedgehog-Patched-Gli signal transduction in reproduction. Biol Reprod. 2003, 69: 8-14. 10.1095/biolreprod.103.015941CrossRefPubMed

14.

Lamm MLG, Bushman W: Hedgehog signalling in prostate morphogenesis. Shh and Gli Signalling and Development. Edited by: Fisher CE, Howie SEM. 2006, 116-124. Landes Bioscience, Austin and Springer, New York.

15.

Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ: Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res. 1992, 7: 683-692.CrossRefPubMed

16.

Yoon JW, Liu CZ, Yang JT, Swart R, Iannaccone P, Walterhouse D: GLI activates transcription through a herpes simplex viral protein 16-like activation domain. J Biol Chem. 1998, 273: 3496-3501. 10.1074/jbc.273.6.3496CrossRefPubMed

17.

Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997, 89: 747-754. 10.1016/S0092-8674(00)80257-3CrossRefPubMed

18.

Karsenty G: Role of Cbfa1 in osteoblast differentiation and function. Semin Cell Dev Biol. 2000, 11: 343-346. 10.1006/scdb.2000.0188CrossRefPubMed

19.

Franceschi RT, Iyer BS, Cui Y: Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res. 1994, 9: 843-854.CrossRefPubMed

20.

Xiao G, Cui Y, Ducy P, Karsenty G, Franceschi RT: Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol Endocrinol. 1997, 11: 1103-1113. 10.1210/me.11.8.1103CrossRefPubMed

21.

Kinto N, Iwamoto M, Enomoto-Iwamoto M, Noji S, Ohuchi H, Yoshioka H, Kataoka H, Wada Y, Yuhao G, Takahashi HE, Yoshiki S, Yamaguchi A: Fibroblasts expressing Sonic hedgehog induce osteoblast differentiation and ectopic bone formation. FEBS Lett. 1997, 404: 319-323. 10.1016/S0014-5793(97)00014-8CrossRefPubMed

22.

Nakamura T, Aikawa T, Iwamoto-Enomoto M, Iwamoto Masahiro, Higuchi Y, Maurizio P, Kinto N, Yamaguchi A, Noji S, Kurisu K, Matsuya T: Induction of osteogenic differentiation by hedgehog proteins. Biochem Biophys Res Commun. 1997, 237: 465-469. 10.1006/bbrc.1997.7156CrossRefPubMed

23.

Yuasa T, Kataoka H, Kinto N, Iwamoto M, Enomoto-Iwamoto M, Iemura S-I, Ueno N, Shibata Y, Kurosawa H, Yamaguchi A: Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2. J Cell Physiol. 2002, 193: 225-232. 10.1002/jcp.10166CrossRefPubMed

24.

Jemtland R, Divieti P, Lee K, Segre GV: Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP secretion. Bone. 2003, 32: 611-620. 10.1016/S8756-3282(03)00092-9CrossRefPubMed

25.

van der Horst G, Farih-Sips H, Löwik CWGM, Karperien M: Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells. Bone. 2003, 33: 899-910. 10.1016/j.bone.2003.07.004CrossRefPubMed

26.

Zhao M, Qiao M, Harris SE, Chen D, Oyajobi BO, Mundy GR: The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol Cell Biol. 2006, 26: 6197-6208. 10.1128/MCB.02214-05PubMedCentralCrossRefPubMed

27.

Shimoyama A, Wada M, Ikeda F, Hata K, Matsubara T, Nifuji A, Noda M, Amano K, Yamaguchi A, Nishimura R, Yoneda T: Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell. 2007, 18: 2411-2418. 10.1091/mbc.E06-08-0743PubMedCentralCrossRefPubMed

28.

Walterhouse D, Ahmed M, Slusarski D, Kalamaras J, Boucher D, Holmgren R, Iannaccone P: gli, a zinc finger transcription factor and oncogene, is expressed during normal mouse development. Dev Dyn. 1993, 196: 91-102.CrossRefPubMed

29.

Bitgood MJ, McMahon AP: Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol. 1995, 172: 126-138. 10.1006/dbio.1995.0010CrossRefPubMed

30.

Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ: Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science. 1996, 273: 613-622. 10.1126/science.273.5275.613CrossRefPubMed

31.

Mo R, Freer AM, Zinyk DL, Crackower MA, Michaud J, Heng HH-Q, Chik KW, Shi X-M, Tsui L-C, Cheng SH, Joyner AL, Hui C-c: Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development. 1997, 124: 113-123.PubMed

32.

St-Jacques B, Hammerschmidt M, McMahon AP: Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 1999, 13: 2072-2086. 10.1101/gad.13.16.2072PubMedCentralCrossRefPubMed

33.

Chung U-i, Schipani E, McMahon AP, Kronenberg HM: Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J Clin Invest. 2001, 107: 295-304. 10.1172/JCI11706PubMedCentralCrossRefPubMed

34.

Long F, Chung U-i, Ohba S, McMahon J, Kronenberg HM, McMahon AP: Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development. 2004, 131: 1309-1318. 10.1242/dev.01006CrossRefPubMed

35.

Colnot C, de la Fuente L, Huang S, Hu D, Lu C, St-Jacques B, Helms JA: Indian hedgehog synchronizes skeletal angiogenesis and perichondrial maturation with cartilage development. Development. 2005, 132: 1057-1067. 10.1242/dev.01649CrossRefPubMed

36.

Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, Nobrega MA, Jacob H, Walterhouse D, Iannaccone P: Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem. 2002, 277: 5548-5555. 10.1074/jbc.M105708200CrossRefPubMed

37.

Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao Y-H, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997, 89: 755-764. 10.1016/S0092-8674(00)80258-5CrossRefPubMed

38.

Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GWH, Beddington RSP, Mundlos S, Olsen BR, Selby PB, Owen MJ: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997, 89: 765-771. 10.1016/S0092-8674(00)80259-7CrossRefPubMed

39.

Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT: Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res. 2002, 17: 101-110. 10.1359/jbmr.2002.17.1.101CrossRefPubMed

40.

Spinella-Jaegle S, Rawadi G, Kawai S, Gallea S, Faucheu C, Mollat P, Courtois B, Bergaud B, Ramez V, Blanchet AM, Adelmant G, Baron R, Roman-Roman S: Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci. 2001, 114: 2085-2094.PubMed

41.

Liao J, McCauley LK: Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev. 2006, 25: 559-571. 10.1007/s10555-006-9033-zCrossRefPubMed

42.

Bailey JM, Singh PK, Hollingsworth MA: Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and Bone morphogenetic proteins. J Cell Biochem. 2007, 102: 829-839. 10.1002/jcb.21509CrossRefPubMed

43.

Lamm MLG, Catbagan WS, Laciak RJ, Barnett DH, Hebner CM, Gaffield W, Walterhouse D, Iannaccone P, Bushman W: Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation. Dev Biol. 2002, 249: 349-366. 10.1006/dbio.2002.0774CrossRefPubMed

Title: Paracrine sonic hedgehog signalling by prostate cancer cells induces osteoblast differentiation
Authors: Samantha M Zunich
Taneka Douglas
Maria Valdovinos
Tiffany Chang
Wade Bushman
David Walterhouse
Philip Iannaccone
Marilyn LG Lamm
Publication date: 01-12-2009
Publisher: BioMed Central
Published in: Molecular Cancer / Issue 1/2009
Electronic ISSN: 1476-4598
DOI: https://doi.org/10.1186/1476-4598-8-12

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2009

Identification of glucocorticoid-induced leucine zipper as a key regulator of tumor cell proliferation in epithelial ovarian cancer

PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signaling

Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma

Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors

PIK3CA alterations in Middle Eastern ovarian cancers

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

Keynote webinar | Spotlight on antibody–drug conjugates in cancer